Appili Therapeutics Inc. Opens the Market
03 7월 2019 - 11:33PM
PR Newswire (Canada)
TORONTO, July 3, 2019 /CNW/ - Kevin Sullivan, Chief Executive Officer, Appili
Therapeutics Inc. (APLI), joined Tim
Babcock, Managing Director, Capital Formation, TSX Venture
Exchange, to open the market. Headquartered in Halifax, Nova Scotia, Appili is a
biopharmaceutical company focused on the acquisition and
development of novel treatments targeting unmet needs in infectious
disease. Appili Therapeutics Inc. commenced trading on TSX Venture
Exchange on June 25, 2019.
SOURCE TMX Group Limited
Copyright 2019 Canada NewsWire
Appili Therapeutics (TSXV:APLI)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Appili Therapeutics (TSXV:APLI)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Appili Therapeutics Inc (TSX 벤처 거래소)의 실시간 뉴스: 최근 기사 0
More TMX Group Limited News Articles